| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/20/2007 | WO2006119107A9 Sclerostin binding agents |
| 09/20/2007 | WO2006082098A8 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 09/20/2007 | WO2005122697A3 Transgenic plants containing a dehydrin gene |
| 09/20/2007 | WO2005092068A3 Novel method of neuroprotection by pharmacological inhibition of amp-activated protein kinase |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2004089310A3 High-throughput assay for virus entry and drug screening |
| 09/20/2007 | WO2004069176A3 Polymer conjugates of mutated neublastin |
| 09/20/2007 | WO2004009834A3 Novel nucleic acids and secreted polypeptides |
| 09/20/2007 | WO2004004649A3 Compositions and methods for the treatment of immune related diseases |
| 09/20/2007 | WO2003011823A3 Crfr1 selective ligands |
| 09/20/2007 | US20070220626 Sequences comprise transcriptional initiation regions associated with seed formation and seed tissues; plant regulatory elements natively associated with the nucleotide sequences coding for maize ; regulation of gene expression in plants, improving seed traits in plants |
| 09/20/2007 | US20070220620 TAT-046 and methods of assessing and treating cancer |
| 09/20/2007 | US20070219767 Atomic coordinates of albumin drug complexes and method of use of pharmaceutical development |
| 09/20/2007 | US20070219357 Chemically modified G-CSF |
| 09/20/2007 | US20070219356 Controlling cell proliferation, cell differentiation; immobilization; prelude to bone marrow transplants; stability, solubility, enhanced circulating half-life and plasma residence times |
| 09/20/2007 | US20070219355 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 09/20/2007 | US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 09/20/2007 | US20070219353 Immune Response Associated Proteins |
| 09/20/2007 | US20070219352 Fibrinogen from transgenic animals |
| 09/20/2007 | US20070219351 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent |
| 09/20/2007 | US20070219349 Isolated GAGE-7B and 8 proteins |
| 09/20/2007 | US20070219348 Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing same |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219346 Glucose sensor and uses thereof |
| 09/20/2007 | US20070219269 Novel aconitase |
| 09/20/2007 | US20070219147 Insect Chymotrypsin and Inhibitors Thereof |
| 09/20/2007 | US20070219136 Methods and compositions for treating inflammatory disorders |
| 09/20/2007 | US20070219134 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/20/2007 | US20070219132 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070219126 Class of bioactive glycoprotein |
| 09/20/2007 | US20070219125 Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using same |
| 09/20/2007 | US20070219117 Bidentate motif and methods of use |
| 09/20/2007 | US20070219116 Follicle Stimulating Hormone Superagonists |
| 09/20/2007 | US20070218565 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid |
| 09/20/2007 | US20070218550 Novel human LXRalpha variants |
| 09/20/2007 | US20070218549 Compositions comprising conditioned cell culture media and uses thereof |
| 09/20/2007 | US20070218547 Self assembling proteins for producing extended materials |
| 09/20/2007 | US20070218527 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218507 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 09/20/2007 | US20070218506 Immunoassays for Buprenorphine and Norbuprenorphine |
| 09/20/2007 | US20070218504 Human leptin-derived polypeptides and uses thereof |
| 09/20/2007 | US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 09/20/2007 | US20070218470 Method for selective inactivation of viral replication |
| 09/20/2007 | US20070218463 Rearranged squamous cell carcinoma antigen genes II |
| 09/20/2007 | US20070218461 Indole-Diterpene Biosynthesis |
| 09/20/2007 | US20070218082 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | US20070218078 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218075 immunogens; glutamine based point mutations |
| 09/20/2007 | US20070218074 Vaccine mixture comprising e6/e7 human papilloma viral amino acid sequences for use as therapeutic targeting tools in treatment of uterine cancer |
| 09/20/2007 | US20070218070 Methods of modulation of the immune system |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218059 Cell Surface Marker |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218051 Epitope peptides immunogenic against Streptococcus pneumoniae |
| 09/20/2007 | US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein |
| 09/20/2007 | US20070218043 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | US20070218001 Biotherapeutics, Diagnostics and Research Reagents |
| 09/20/2007 | US20070218000 component of outer membrane preparations of Neisseria meningitidis capable of inducing bactericidal activity; formulations with the ability to increase the protective spectrum of existing vaccines and hence expanding it against different pathogens |
| 09/20/2007 | US20070217999 Excretable Reporter Systems |
| 09/20/2007 | US20070215475 Factor VIII separation |
| 09/20/2007 | DE19882435B4 Verfahren zur Hemmung von Krebszellwachstum mit einem pRb2/p130 exprimierenden Vektor Methods of inhibiting cancer cell growth with a pRb2 / p130 expressing vector |
| 09/20/2007 | CA2646520A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/20/2007 | CA2645740A1 Multivalent clostridial toxins |
| 09/20/2007 | CA2645344A1 Proteins, nucleic acids and medicaments |
| 09/20/2007 | CA2645342A1 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| 09/20/2007 | CA2645109A1 Protein folding |
| 09/20/2007 | CA2645097A1 Anti-5t4 antibodies and uses thereof |
| 09/20/2007 | CA2638975A1 Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus |
| 09/20/2007 | CA2638862A1 Pegylated mutated clostridium botulinum toxin |
| 09/20/2007 | CA2607677A1 Catalase gene and use thereof |
| 09/20/2007 | CA2601537A1 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/19/2007 | EP1835030A1 OB fusion protein compositions and methods |
| 09/19/2007 | EP1835029A1 Papillomavirus vaccines |
| 09/19/2007 | EP1835028A1 The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1834963A1 Di-polymer protein conjugates and processes for their preparation |
| 09/19/2007 | EP1834962A1 PEGylated mtutated Clostridium botulinum toxin |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834267A2 Pf4 pharmacophores and their uses |
| 09/19/2007 | EP1833993A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/19/2007 | EP1833992A2 Pcv2 immunogenic compositions and methods of producing such compositions |
| 09/19/2007 | EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same |
| 09/19/2007 | EP1833972A2 Plants having increased yield and method for making the same |
| 09/19/2007 | EP1833970A2 Methods for producing soluble multi-membrane-spanning proteins |
| 09/19/2007 | EP1833848A2 Novel tnf receptor regulatory domain |
| 09/19/2007 | EP1833847A2 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides |
| 09/19/2007 | EP1833845A2 Adiponectin variants |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1833843A1 Synthesis of peptide t-20 using peptide intermediate fragments |
| 09/19/2007 | EP1833841A1 Method for preventing formation of trisulfide derivatives of polypeptides |
| 09/19/2007 | EP1833508A2 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/19/2007 | EP1833507A1 Compositions for immunizing against mycobacterium |
| 09/19/2007 | EP1833504A2 Sustained delivery of pdgf using self-assembling peptide nanofibers |